1-13 of 13
Guillaume Manson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Severe infections after CD19-directed chimeric antigen receptor T-cell therapy for Relapsed/Refractory large B-cell lymphoma, a retrospective real-life study from the DESCAR-T registry (LYSA)

Free
Tiy Morris, Amandine Fayard, Vivien Dupont, Elisabeth Daguenet, Catherine Thieblemont, Emmanuel Bachy, Guillaume Manson, Charles Herbaux, Ibrahim Yakoub-Agha, Thomas Gastinne, Didier Blaise, Louise Roulin, François-Xavier Gros, Pierre Bories, Roch Houot, Steven Le Gouill, Elisabeth Botelho-Nevers, Ludovic Fouillet, Jerome Cornillon
Journal: Blood
Blood (2025) 146 (Supplement 1): 1014.
https://doi.org/10.1182/blood-2025-1014
Published: 2025
Journal Articles

Impact of the number of bridging therapy lines on outcomes after axi-cel in LBCL: A lysa study from the descar-T registry

Free
Guillaume Manson, Cécile Pizot, Emmanuel Bachy, Catherine Thieblemont, Roch Houot, Franck Morschhauser, Charles Herbaux, Gabriel Brisou, Fabien Le Bras, Pierre Bories, François-Xavier Gros, Marie-Thérèse Rubio, Benoit Tessoulin, Blandine Guffroy, Julie Abraham, Cedric Rossi, Cristina Castilla-Llorente, Clemence Hameon, Fabrice Jardin, Magalie Joris, Sylvain Carras, Stephanie Guidez, Michael Loschi, Adrien Chauchet, Justine Decroocq, Olivier Hermine, Mohamad Mohty, Jacques-Olivier Bay, Aline Schmidt, Gandhi Damaj, Choquet Sylvain, Laure Lebras, Laura Herbreteau, Ludovic Fouillet, Steven Le Gouill, Remy Dulery
Journal: Blood
Blood (2025) 146 (Supplement 1): 2745.
https://doi.org/10.1182/blood-2025-2745
Published: 2025
Journal Articles

Outcome of patients with large B-cell lymphoma relapsing after second-line CAR-t: Insights from the descar-t registry

Free
Pierre Sesques, Guillaume Manson, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Cristina Castilla-Llorente, Gabriel Brisou, Pierre Bories, Catherine Thieblemont, Laurianne Drieu La Rochelle, Benoit Tessoulin, Axel André, Cedric Rossi, Jérôme Paillassa, Stephanie Guidez, Antoine CAPES, Laura Herbreteau, Sylvain Choquet, Jacques-Olivier Bay, Adrien Chauchet, Laure Lebras, Fabien Claves, Julie Abraham, Jean-Valère Malfuson, Marie-Thérèse Rubio, Justine Decroocq, Luc-Matthieu Fornecker, Gandhi Damaj, Ludovic Fouillet, Magalie Joris, Michael Loschi, Olivier Hermine, Hadia Hafirassou, Emelie Van Zele, Vivien Dupont, Steven Le Gouill, Roch Houot, Vincent Camus
Journal: Blood
Blood (2025) 146 (Supplement 1): 956.
https://doi.org/10.1182/blood-2025-956
Published: 2025
Journal Articles

CARs in pole position: ready for the race?

Free
Clinical Trials & Observations
Guillaume Manson, Roch Houot
Journal: Blood
Blood (2025) 145 (20): 2235–2236.
https://doi.org/10.1182/blood.2025028354
Published: 2025
Journal Articles

Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated in 3rd Line and Beyond: A Multicenter Cohort Study from the French Hemsys Tumor Board Database

Free
Guillaume Manson, Florence Broussais, Laurent Dumartin, Guillaume codet De Boisse, Roch Houot
Journal: Blood
Blood (2024) 144 (Supplement 1): 6336.
https://doi.org/10.1182/blood-2024-204643
Published: 2024
Journal Articles

Impact of Paraclinical Investigations in the Management of CAR T-Cell-Associated Neurotoxicity: Lessons Learned from Real World Experience

Free
Mattéo Mauget, Guillaume Manson, Roch Houot
Journal: Blood
Blood (2023) 142 (Supplement 1): 4881.
https://doi.org/10.1182/blood-2023-180199
Published: 2023
Journal Articles

Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classical Hodgkin Lymphoma: Analysis of a Large International Cohort

Free
Reid W Merryman, MD, Luca Castagna, MD, Paolo Corradini, MD, Vincent T. Ho, MD, David A. Bond, MD, Samantha Jaglowski, MDMPH, Michael A Spinner, Sally Arai, MD, Robert Lowsky, MD, Alex F. Herrera, MD, Anna Guidetti, MD, Geoffrey Shouse, DO, PhD, Didier Blaise, MD PhD, Jean Marc Schiano De Colella, MD, Talha Badar, MD, Mehdi Hamadani, MD, Stephen M Ansell, MD PhD, Yago Nieto, MD PhD, Chloe Spilleboudt, MD, Tatyana A. Feldman, MD, Lori Dahncke, BSN, Anurag K. Singh, MD, Joseph P. McGuirk, DO, Mohamad Mohty, MD PhD, Remy Dulery, MD, Aspasia Stamatoulas Bastard, Roch Houot, MD PhD, Guillaume Manson, MD, Marie-Pierre Moles, MD, Corentin Orvain, MD, Kamal Bouabdallah, MD, Matthew J. Frigault, MD, Yi-Bin Chen, Ryan C. Lynch, MD, Stephen D. Smith, MD, Uttam Rao, MD, Michael T Byrne, DO, Jason Romancik, MD, Jonathon B. Cohen, MDMS, Robin M. Joyce, MD, Maryam Rahimian, MD, Asad Bashey, MD PhD, Hatcher J. Ballard, BS, Jakub Svoboda, MD, Laura Giordano, Valter Torri, Beatrice Casadei, MD, Martina Sollini, MD, Chiara De Philippis, MD, Massimo Magagnoli, MD, Armando Santoro, Philippe Armand, MD PhD, Pier Luigi Zinzani, MD PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 775.
https://doi.org/10.1182/blood-2019-125039
Published: 2019
Journal Articles

Risk of Relapse after Anti-PD1 Discontinuation and Efficacy of Anti-PD1 Re-Treatment in Patients with Hodgkin Lymphoma

Free
Guillaume Manson, Pauline Brice, Charles Herbaux, MD MSc, Maria Silva, Krimo Bouabdallah, MD, Bénédicte Deau-Fisher, MD, Juliette Bouteloup, MD, Jean Marc Schiano de Collela, MD, Emmanuelle Nicolas-Virelizier, Marie Maerevoet, MD, Herve Ghesquieres, MD PhD, Aspasia Stamatoulas Bastard, Chloe Antier, Florence Poizeau, Laurent Dercle, MD, Roch Houot, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1549.
https://doi.org/10.1182/blood-2019-122171
Published: 2019
Journal Articles

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma: Real World Evidence from the French Early Access Program

Free
Guillaume Manson, MD, Jean-Baptiste Mear, MD, Charles Herbaux, MD, Jean Marc Schiano de Collela, MD, Rene-Olivier Casasnovas, MD, Aspasia Stamatoullas, MD, Bénédicte Deau-Fisher, MD, Anna Schmitt, Georges Garnier, MD, Lysiane Molina, MD, Krimo Bouabdallah, MD, Marie-Pierre Moles, Herv Ghesquieres, Adrian Tempescul, MD, Remy Dulery, MD, Emmanuelle Nicolas-Virelizier, MD, Alain Jacques Delmer, MD, Cecile Borel, MD, Adrien Chauchet, MD, Laurent Dercle, MD, Pauline Brice, MD, Roch Houot, Pr, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1638.
https://doi.org/10.1182/blood-2018-99-110960
Published: 2018
Journal Articles

Prolonged remissions after anti-PD-1 discontinuation in patients with Hodgkin lymphoma

Free
Clinical Trials & Observations
Guillaume Manson, Charles Herbaux, Pauline Brice, Krimo Bouabdallah, Aspasia Stamatoullas, Jean-Marc Schiano, Hervé Ghesquieres, Laurent Dercle, Roch Houot
Journal: Blood
Blood (2018) 131 (25): 2856–2859.
https://doi.org/10.1182/blood-2018-03-841262
Published: 2018
Journal Articles

Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma

Free
Clinical Trials & Observations
Charles Herbaux, Jordan Gauthier, Pauline Brice, Elodie Drumez, Loic Ysebaert, Hélène Doyen, Luc Fornecker, Krimo Bouabdallah, Guillaume Manson, Hervé Ghesquières, Reza Tabrizi, Eric Hermet, Julien Lazarovici, Anne Thiebaut-Bertrand, Adrien Chauchet, Hélène Demarquette, Eileen Boyle, Roch Houot, Ibrahim Yakoub-Agha, Franck Morschhauser
Journal: Blood
Blood (2017) 129 (18): 2471–2478.
https://doi.org/10.1182/blood-2016-11-749556
Published: 2017
Journal Articles

Clinical Efficacy of the Rivbd Combination for Refractory/Relapsed (R/R) Mantle Cell Lymphoma (MCL) Patients: A Retrospective Study of the French Lysa Group

Free
Caroline Régny, Sandra Malak, Guillaume Manson, Clementine Sarkozy, Aline Clavert, Charles Herbaux, Adrien Chauchet, Eric Jourdan, Laurence Sanhes, MD, Pascal Godmer, Laurent Pascal, Katell Le Du, Laurent Sutton, Laurent Voillat, Jehan Dupuis, Bruno Anglaret, Remy Gressin, MD
Journal: Blood
Blood (2016) 128 (22): 1111.
https://doi.org/10.1182/blood.V128.22.1111.1111
Published: 2016
Journal Articles

Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC

Free
Charles Herbaux, MD, Jordan Gauthier, MD, Pauline Brice, MD, Luc Fornecker, MD, Krimo Bouabdallah, MD, Guillaume Manson, Hervé Ghesquières, MD, Anne Thiebaut-Bertrand, MD, Hélène Demarquette, Eileen Boyle, Loic Ysebaert, MD PhD, Roch Houot, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Franck Morschhauser, MD
Journal: Blood
Blood (2015) 126 (23): 3979.
https://doi.org/10.1182/blood.V126.23.3979.3979
Published: 2015